Mask Dead Space Testing: Inhaled CO2 Content Evaluation for Respirators and Face Masks

Mask dead space testing measures the average carbon dioxide content of the air inhaled inside a respirator, verifying that the design does not cause excessive rebreathing of exhaled gas. The test is a mandatory requirement under EN 149:2001+A1:2009 and GB 2626-2019 for FFP, KN, and similar particulate respirators submitted for certification. This article explains the testing principle, sample requirements, instrumentation, procedures, and acceptance criteria applied by accredited third-party laboratories.

Technical Overview

Dead space in a mask refers to the enclosed gas volume between the inner surface of the facepiece and the wearer's face, including the region around the nose and mouth. Because exhaled air rich in carbon dioxide temporarily accumulates in this volume, a portion of it is inevitably re-inhaled during the next breathing cycle. If the dead space is poorly designed or excessively large, the concentration of carbon dioxide in the inhaled air can rise to levels associated with headache, dizziness, shortness of breath, and reduced concentration, particularly during sustained physical work.

International and national standards therefore treat dead space not as a simple geometric measurement but as a functional safety requirement. Instead of measuring the physical internal volume of the mask, standards such as EN 149:2001+A1:2009 (filtering half masks used for protection against particles) and GB 2626-2019 (respiratory protection against particulates) require the measurement of the average carbon dioxide content of the inhaled air. In both standards, the average inhaled CO2 concentration shall not exceed 1.0% by volume.

Several design factors influence the dead space performance of a mask, including the total internal volume, the three-dimensional cup or folding structure, the presence and efficiency of an exhalation valve, the fit of the nose clip and nose foam, the permeability of the filter material itself, and how closely the facepiece sits against the face. Mask dead space testing provides manufacturers, regulators, and buyers with objective evidence that these design elements work together to keep rebreathed carbon dioxide within safe limits.

Testing Samples

Filtering Half Masks (FFP1, FFP2, FFP3)

Disposable filtering half masks intended for the European market under EN 149:2001+A1:2009 are the primary category subject to mandatory dead space testing. This includes both valved and non-valved versions, cup-shaped and flat-folding constructions, in all declared sizes.

Particulate Respirators under GB 2626 (KN90, KN95, KN100)

Respirators sold in China under GB 2626-2019 must demonstrate that the carbon dioxide content of the inhaled air does not exceed the specified limit. The standard covers disposable, replaceable-filter, and powered air-purifying particulate respirator configurations where applicable.

Reusable Half Masks and Full Face Masks

Half masks conforming to EN 140 and full face masks conforming to EN 136 are also evaluated for carbon dioxide buildup in the inhaled air, since their rigid bodies create significant internal volume. Gas masks and combination respirators under related EN and GB standards follow similar principles.

Other Face Coverings and Medical Masks

Surgical masks under EN 14683 and ASTM F2100, as well as community face coverings, are generally not required to pass a dead space test for regulatory purposes. However, manufacturers frequently commission inhaled CO2 assessments during product development to compare comfort, ventilation, and valve effectiveness across designs.

Sample Preparation Requirements

• Samples must be unused, clean, and in as-supplied condition, complete with all components such as head harnesses, nose clips, nose foam, and exhalation valves.
• All declared sizes or the complete size range of the model should be represented, since fit and internal volume vary between sizes.
• Where specified by the applicable standard, samples may be conditioned in a defined temperature and humidity environment prior to testing.
• Sufficient units should be provided to accommodate repeat measurements and multiple test subjects or repeated simulator runs.

Testing Items

The core testing item for dead space evaluation is the average carbon dioxide content of the inhaled air, expressed as a percentage by volume. Supplementary evaluations may be included depending on the purpose of the test program:

• Average CO2 concentration of inhaled air (primary dead space indicator, limit 1.0% by volume under EN 149 and GB 2626-2019).
• Geometric internal volume of the mask, used as a design and benchmarking parameter.
• Comparative inhaled CO2 results for valved versus non-valved variants of the same model.
• Effect of different head harness tension settings or nose clip adjustments on inhaled CO2 levels.

Results are reported with the test conditions, breathing parameters, and a clear pass or fail statement against the acceptance criterion of the referenced standard.

Testing Methods

Principle

All recognized dead space methods share the same logic: the mask is worn (by a human subject or mounted on a standard headform connected to a breathing simulator), a gas sampling probe is positioned in the breathing zone inside the mask, and the carbon dioxide concentration is continuously recorded by a calibrated analyzer. Only the CO2 values measured during the inhalation phases are used to compute the average, which is then compared with the limit value.

Human Subject Method (EN 149 Type Procedures)

In the approach specified for filtering half masks under EN 149:2001+A1:2009, trained test subjects wear the mask while performing standardized activity, typically walking on a treadmill under controlled conditions. A thin sampling line is routed to the interior of the mask without disturbing the seal, with its opening positioned in the breathing zone. An infrared carbon dioxide analyzer draws a continuous sample of the internal gas. The average CO2 concentration over the inhalation portions of several consecutive breaths is calculated, and the result must not exceed 1.0% by volume. Testing across multiple subjects of different facial dimensions provides confidence that the result is representative.

Breathing Simulator and Headform Method (GB 2626 Type Procedures)

For respirators tested under GB 2626-2019, a mechanical breathing simulation is employed to remove subject-to-subject variability. The respirator is mounted on a standard headform fitted with a sampling port in the nose and mouth region. A breathing machine generates a defined respiratory pattern with specified breathing rate and tidal volume, while the simulated exhaled gas contains carbon dioxide at a controlled concentration representative of human exhalation. The analyzer records the CO2 level inside the mask, and the average concentration of the gas drawn in during each inhalation phase is computed. The result must not exceed 1.0% by volume.

Instrumentation and Equipment

• Calibrated infrared carbon dioxide analyzer with appropriate measurement range and fast response time.
• Motorized treadmill for human subject protocols, with speed control matching the specified workload.
• Mechanical breathing simulator (artificial lungs) with adjustable respiratory rate and tidal volume for headform protocols.
• Standard headform with internal gas sampling port and mask mounting fixture.
• Gas mixing and flow control equipment to generate exhaled gas with stable CO2 concentration.
• Environmental monitoring for temperature, humidity, and barometric pressure, plus data acquisition software for breath-phase analysis.

Calculation and Reporting

The analyzer signal is separated into inhalation and exhalation phases. The arithmetic mean of the CO2 concentrations recorded during the inhalation phases of the evaluated breath cycles is calculated and reported as the average inhaled CO2 content. The test report identifies the sample description, applied standard, test arrangement, environmental conditions, individual and mean results, and a conformity statement against the 1.0% limit. Where multiple sizes or variants are tested, results are tabulated for each configuration.

Applications

• Certification support for FFP1, FFP2, and FFP3 filtering half masks placed on the market under the PPE Regulation (EU) 2016/425 with EN 149 as the harmonized specification.
• Compliance demonstration for KN-series and other particulate respirators under GB 2626-2019 for the Chinese market.
• Type examination and conformity assessment of half masks under EN 140 and full face masks under EN 136.
• Research and development optimization of mask geometry, internal support structures, exhale valve selection, and sealing components to minimize CO2 rebreathing.
• Batch quality control and supplier verification programs comparing production consistency against approved reference samples.
• Comparative comfort studies and marketing substantiation for premium valved or low-dead-space designs.
• Academic and occupational hygiene research into physiological load and wearer acceptance of respiratory protective equipment.

FAQ

What is dead space in a mask?

Dead space is the internal gas volume of the mask between the facepiece and the wearer's face. Exhaled air lingers in this volume and is partially rebreathed, so an inefficient design raises the carbon dioxide level of the next inhalation.

Why is CO2 measured instead of the physical volume of the mask?

Physical volume alone does not determine how much exhaled gas is actually rebreathed. Geometry, airflow pathways, valve behavior, and material permeability all affect gas exchange inside the mask. Measuring the average inhaled CO2 concentration is a direct, functional assessment of the actual physiological burden on the wearer.

What is the acceptance limit for dead space testing?

Under both EN 149:2001+A1:2009 and GB 2626-2019, the average carbon dioxide content of the inhaled air shall not exceed 1.0% by volume. Other respiratory equipment standards specify their own limits for the relevant device category.

Do exhalation valves reduce dead space effects?

Yes. A properly functioning exhalation valve vents the majority of exhaled gas directly to the atmosphere instead of allowing it to accumulate inside the facepiece, which typically lowers inhaled CO2 concentration and breathing humidity at the same time.

Is dead space testing mandatory for surgical masks and community face coverings?

No. Standards such as EN 14683 and ASTM F2100 for medical masks do not include a dead space requirement. However, inhaled CO2 assessments are still valuable for design comparison, comfort claims, and ergonomic studies.

How many samples and test runs are required?

Requirements vary by standard. Human subject protocols under EN 149 involve testing on multiple subjects with different facial characteristics, while simulator-based protocols under GB 2626 rely on repeated mechanical runs with defined breathing parameters. Accredited third-party laboratories determine the exact number based on the applicable standard and the model's size range.

How can manufacturers reduce dead space in design?

Effective measures include minimizing unnecessary internal volume, using supportive yet low-profile structures, integrating an efficient exhalation valve, improving nose clip and foam conformity, and ensuring filter media with adequate permeability so that gas exchange through the material is not restricted.